Organization of Units of Translational Research (UTRs)

Organization of Units of Translational Research (UTRs)

The ultimate goal of molecular medicine research is to translate the scientific findings and results to putative clinical applications – as closely to human conditions as possible. Therefore, the establishment of multiple UTRs is a core component of the HCEMM organization. Logistically, by creating UTRs, formally designated collaborative research groups will emerge which will include both participating practicing clinical scientists, and experts of the molecular medicine field. These laboratories would carry out translational projects, in which basic-applied research activities will be accompanied by significant clinical components. The infrastructural and conceptual bases of UTRs are already available at the large University Hospitals of the founding institutions. Specifically, the following ‘translational strengths’ were identified: translation research of cardiovascular diseases; of infectious, immunological and inflammatory diseases; and of metabolic syndrome and related diseases. With the organization of the novel HCEMM, the currently separated entities (besides their evident improvements) will be coordinated by the Headquarter; moreover, if deemed necessary throughout the continuous evaluation of the HCEMM, new UTRs with novel focuses will also be established. Hence, the joint operation and constant development of UTRs at the different sites of HCEMM will lead to a major competitive advantage by offering immediate and non-restricted access to human data, biological samples of patients, as well as a relatively easy path to clinical trials and drug development. Collectively, this unique set-up will result in clear advantage and impact for not only basic, applied and translational scientists but also for pharma and biotech partners.
This website uses cookies. For more information visit the Cookies & Privacy Policy page.